您当前的位置：
首页 >
文章列表页 >
Clinical Efficacy of Rujietai Capsules in Treating 2 406 Cases of Breast Pain，Lumps and Other Symptoms of Breast Hyperplasia： A Multicenter，Real-world Clinical Study
更新时间：2024-07-12

    • Clinical Efficacy of Rujietai Capsules in Treating 2 406 Cases of Breast Pain，Lumps and Other Symptoms of Breast Hyperplasia： A Multicenter，Real-world Clinical Study

    • “In the field of breast hyperplasia treatment, a multicenter clinical trial has validated the safety and efficacy of Rujietai capsules, providing data support for rational drug use and re registration in clinical practice. The research results show that Rujietai capsules can significantly alleviate patients' symptoms, improve traditional Chinese medicine syndromes, have definite therapeutic effects, and have good safety.”
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 30, Issue 16, Pages: 123-131(2024)

    • DOI：10.13422/j.cnki.syfjx.20241898    

      CLC： R242;R969.4;R256.4;R856.5;R2-031;R655.8;R271.1

    • Received：16 May 2024，

      Published Online：19 June 2024，

      Published：20 August 2024

    移动端阅览

  • HAN Jianke,ZHANG Dongxiao,SUN Li,et al.Clinical Efficacy of Rujietai Capsules in Treating 2 406 Cases of Breast Pain，Lumps and Other Symptoms of Breast Hyperplasia： A Multicenter，Real-world Clinical Study[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(16):123-131. DOI： 10.13422/j.cnki.syfjx.20241898.

  •  
  •  

0

Views

37

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Treatment of Diabetic Retinopathy with Blood Stasis， Collateral Obstruction， and Qi and Yin Deficiency Syndrome with Tongluo Mingmu Capsules： A Randomized， Double-blind， and Multi-center Phase Ⅲ Clinical Trial
A Multicenter， Randomized， Double-blind， and Placebo-parallel Controlled Trial of Tibetan Medicine Ruyi Zhenbaowan in Treatment of Knee Osteoarthritis
Application of Quality Evaluation of Blind Method in Clinical Trials of Traditional Chinese Medicine

Related Author

HAN Jianke
SUN Li
YANG Libo
GUO Xiaoteng
WANG Xiaofang
GAO Xuedong
REN Junxia
WANG Yongzheng

Related Institution

National Key Laboratory for Innovation and Transformation of Luobing Theory， Shijiazhuang Yiling Pharmaceutical Co. Ltd.
National Key Laboratory of Collaterals Theory Innovation and Transformation， Shijiazhuang Yiling Pharmaceutical Co.Ltd.
The First Affiliated Hospital of Hunan University of TCM
Affiliated Hospital of Changchun University of TCM Changchun
Dongfang Hospital of Beijing University of Chinese Medicine
0